 reuters    the u s  house of representatives is expected to pass a    billion piece of legislation on wednesday designed to spur medical innovation  speed access to new drugs  expand mental health treatment  and combat opioid abuse  the bill  known as the  century cures act  provides    billion to the national institutes of health  nih  over  years to support brain  cancer and precision medicine research  it also provides   million to the food and drug administration to approve drugs and devices more quickly  president elect donald trump has promised to cut  red tape  at the fda  he has not commented specifically on  century cures  the u s  senate is expected to vote on the bill next week  it is expected to pass  though possibly not before some additional changes are made  it would then go to president barack obama for signature  the bill calls for   billion over two years to treat and prevent opioid abuse  including improving prescription drug monitoring programs  training for health care providers  and expanding access to opioid treatment programs  critics of the bill  including senator elizabeth warren of massachusetts  a democrat  said it contains too many give aways to the pharmaceutical industry and will allow companies to push treatments with limited proof of efficacy  speaking on the senate floor on monday  warren said she could not vote for the bill despite its many positive elements and would not be a  lackey  for the drug industry  warren  along with republican senator charles grassley of iowa  also objects to a provision that would allow companies to hide payments to doctors under the auspices of continuing medical education  grassley co authored the sunshine act which led to the creation of a database listing drug and device company payments to doctors   a lot of earlier payments to doctors were under the umbrella of continuing medical education   grassley said in a statement on monday   we shouldn t create a loophole that would let drug and medical device companies mask their payments to doctors under a payment category that s too broad and could gut the spirit and the letter of the sunshine act   the bill would add an additional reporting exemption for physicians who receive indirect payments for speaking fees  patients groups hailed the bill  saying it would bring patient voices to the center of the drug approval process   this is a patient centered bill   said ellen sigal  chair and founder of friends of cancer research  a patient advocacy organization   it fosters innovation and doesn t lower safety standards   